Laboratory Corporation of America Holdings

$221.06
(as of Oct 23, 11:27 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Laboratory Corporation of America Holdings

Stock Price
$221.07
Ticker Symbol
LH
Exchange
NYSE

Industry Information for Laboratory Corporation of America Holdings

Sector
Healthcare
Industry
Diagnostics & Research

Company Description for Laboratory Corporation of America Holdings

Country
USA
Full Time Employees
67,000

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.

Fundamentals for Laboratory Corporation of America Holdings

Market Capitalization
$18,514,745,344
EBITDA
$1,655,800,064
Dividends per Share
$2.88
P/E Ratio
41.06
Forward P/E Ratio
13.53
Earnings per Share
$5.37
Earnings per Share Estimate Next Year
$15.87
Profit Margin
3.60%
Shares Outstanding
83,963,296
Percent Owned by Insiders
0.33%
Percent Owned by Institutions
95.68%
52-Week High
$237.72
52-Week Low
$191.37

Technical Indicators for Laboratory Corporation of America Holdings

50-Day Moving Average
$222.44
200-Day Moving Average
$214.35
RSI
54.26
4.16

Analyst Ratings for Laboratory Corporation of America Holdings

Strong Buy
9
Buy
2
Hold
7
Sell
0
Strong Sell
0

News About Laboratory Corporation of America Holdings

Oct 21, 2024, 9:16 AM EST
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. See more.
Oct 18, 2024, 9:00 AM EST
Oct 16, 2024, 8:00 AM EST
First To Know® Syphilis Test With Box - Credit NOWDiagnostics (Photo: Business Wire) See more.
Oct 14, 2024, 9:22 AM EST
Labcorp Holdings Inc. See more.
Oct 10, 2024, 8:30 AM EST
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide See more.